• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在果蝇中,化疗诱导的毒性具有高度遗传性。

Chemotherapy-induced toxicity is highly heritable in Drosophila melanogaster.

机构信息

Department of Ecology and Evolution, University of California, Irvine, California, USA.

出版信息

Pharmacogenet Genomics. 2012 Apr;22(4):285-9. doi: 10.1097/FPC.0b013e3283514395.

DOI:10.1097/FPC.0b013e3283514395
PMID:22336958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3303944/
Abstract

OBJECTIVES

Identification of the genes responsible for chemotherapy toxicity in Drosophila melanogaster may allow for the identification of human orthologs that similarly mediate toxicity in humans. To develop D. melanogaster as a model of dissecting chemotoxicity, we first need to develop standardized high-throughput toxicity assays and prove that the interindividual variation in toxicity as measured by such assays is highly heritable.

METHODS

We developed a method for the oral delivery of commonly used chemotherapy drugs to Drosophila. Post-treatment female fecundity displayed a dose-dependent response to varying levels of the chemotherapy drug delivered. We fixed the dose for each drug at a level that resulted in a 50% reduction in fecundity and used a paternal half-sibling heritability design to calculate the heritability attributable to chemotherapy toxicity assayed by a decrease in female fecundity. The chemotherapy agents tested were carboplatin, floxuridine, gemcitabine hydrochloride, methotrexate, mitomycin C, and topotecan hydrochloride.

RESULTS

We found that six currently widely prescribed chemotherapeutic agents lowered fecundity in D. melanogaster in both a dose-dependent and a highly heritable manner. The following heritability estimates were found: carboplatin, 0.72; floxuridine, 0.52; gemcitabine hydrochloride, 0.72; methotrexate, 0.99; mitomycin C, 0.64; and topotecan hydrochloride, 0.63.

CONCLUSION

The high heritability estimates observed in this study, irrespective of the particular class of drug examined, suggest that human toxicity may also have a sizable genetic component.

摘要

目的

鉴定导致黑腹果蝇化疗毒性的基因,可能有助于鉴定在人类中同样介导毒性的人类同源基因。为了将黑腹果蝇发展为剖析化学毒性的模型,我们首先需要开发标准化的高通量毒性测定法,并证明此类测定法所测量的个体间毒性差异具有高度遗传性。

方法

我们开发了一种向果蝇口服给予常用化疗药物的方法。经处理的雌性果蝇的生育力对所给予的化疗药物剂量呈剂量依赖性反应。我们将每种药物的剂量固定在导致生育力降低 50%的水平,并采用父系半同胞遗传设计,根据雌性生育力下降来计算归因于化疗毒性的遗传力。所测试的化疗药物为卡铂、氟尿嘧啶、盐酸吉西他滨、甲氨蝶呤、丝裂霉素 C 和盐酸拓扑替康。

结果

我们发现,目前广泛使用的六种化疗药物均以剂量依赖性和高度遗传性的方式降低了黑腹果蝇的生育力。发现的遗传力估计值如下:卡铂,0.72;氟尿嘧啶,0.52;盐酸吉西他滨,0.72;甲氨蝶呤,0.99;丝裂霉素 C,0.64;盐酸拓扑替康,0.63。

结论

本研究观察到的高遗传力估计值,无论所检查的特定药物类别如何,均表明人类毒性也可能具有相当大的遗传成分。

相似文献

1
Chemotherapy-induced toxicity is highly heritable in Drosophila melanogaster.在果蝇中,化疗诱导的毒性具有高度遗传性。
Pharmacogenet Genomics. 2012 Apr;22(4):285-9. doi: 10.1097/FPC.0b013e3283514395.
2
Using Drosophila melanogaster to identify chemotherapy toxicity genes.利用黑腹果蝇鉴定化疗毒性基因。
Genetics. 2014 Sep;198(1):31-43. doi: 10.1534/genetics.114.161968.
3
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).拓扑替康联合卡铂对比紫杉醇联合卡铂(PC)或吉西他滨联合卡铂(GC)或聚乙二醇脂质体阿霉素联合卡铂(PLDC)的标准治疗:NOGGO-AGO-Study Group-AGO 奥地利和 GEICO-ENGOT-GCIG 协作组的一项随机 III 期试验(HECTOR)。
Ann Oncol. 2016 Dec;27(12):2236-2241. doi: 10.1093/annonc/mdw418. Epub 2016 Oct 26.
4
Recurrent ovarian cancer.复发性卵巢癌
Onkologie. 2004 Feb;27(1):7-8. doi: 10.1159/000075599.
5
The genetic architecture of methotrexate toxicity is similar in Drosophila melanogaster and humans.甲氨蝶呤毒性的遗传结构在黑腹果蝇和人类中相似。
G3 (Bethesda). 2013 Aug 7;3(8):1301-10. doi: 10.1534/g3.113.006619.
6
Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.新辅助吉西他滨加卡铂治疗局部晚期膀胱癌。
Jpn J Clin Oncol. 2013 Feb;43(2):193-9. doi: 10.1093/jjco/hys213. Epub 2012 Dec 28.
7
A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy.拓扑替康联合吉西他滨治疗一线化疗失败后复发卵巢癌患者的II期研究。
Ann Oncol. 2002 Nov;13(11):1749-55. doi: 10.1093/annonc/mdf294.
8
Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinum.对于一线使用紫杉醇和铂类化疗失败后的复发性卵巢癌患者,进行拓扑替康与吉西他滨联合治疗的剂量探索性研究。
Onkologie. 2004 Feb;27(1):58-64. doi: 10.1159/000075607.
9
Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.随机 II/III 期试验评估吉西他滨/卡铂和甲氨蝶呤/卡铂/长春碱在不适合顺铂为基础化疗的晚期尿路上皮癌患者中的应用:EORTC 研究 30986 的 II 期结果。
J Clin Oncol. 2009 Nov 20;27(33):5634-9. doi: 10.1200/JCO.2008.21.4924. Epub 2009 Sep 28.
10
A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.一项用于治疗晚期苗勒氏恶性肿瘤的三种序贯双联方案的II期试验。
Gynecol Oncol. 2003 Nov;91(2):293-8. doi: 10.1016/s0090-8258(03)00496-7.

引用本文的文献

1
Three recent sex chromosome-to-autosome fusions in a Drosophila virilis strain with high satellite DNA content.一个具有高卫星 DNA 含量的 Drosophila virilis 品系中三个最近的性染色体到常染色体融合。
Genetics. 2023 May 26;224(2). doi: 10.1093/genetics/iyad062.
2
Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.长春新碱诱导的周围神经病的药物基因组学研究提示药物代谢动力学和遗传性神经病基因的作用。
Clin Pharmacol Ther. 2019 Feb;105(2):402-410. doi: 10.1002/cpt.1179. Epub 2018 Aug 17.
3
Natural diversity facilitates the discovery of conserved chemotherapeutic response mechanisms.

本文引用的文献

1
'Genetic profiling' and ovarian cancer therapy (review).“基因谱分析”与卵巢癌治疗(综述)。
Mol Med Rep. 2011 Sep-Oct;4(5):771-7. doi: 10.3892/mmr.2011.512. Epub 2011 Jun 17.
2
Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.叶酸代谢途径中遗传多态性与儿童急性淋巴细胞白血病和恶性淋巴瘤中甲氨蝶呤药代动力学和毒性的关系。
Eur J Clin Pharmacol. 2011 Oct;67(10):993-1006. doi: 10.1007/s00228-011-1046-z. Epub 2011 Apr 21.
3
Relationship between single nucleotide polymorphisms in the deoxycytidine kinase gene and chemosensitivity of gemcitabine in six pancreatic cancer cell lines.
自然多样性有助于发现保守的化疗反应机制。
Curr Opin Genet Dev. 2017 Dec;47:41-47. doi: 10.1016/j.gde.2017.08.002. Epub 2017 Sep 9.
4
Using Drosophila melanogaster to identify chemotherapy toxicity genes.利用黑腹果蝇鉴定化疗毒性基因。
Genetics. 2014 Sep;198(1):31-43. doi: 10.1534/genetics.114.161968.
5
Drosophila melanogaster: a first step and a stepping-stone to anti-infectives.果蝇:抗感染药物研究的第一步和踏脚石。
Curr Opin Pharmacol. 2013 Oct;13(5):763-8. doi: 10.1016/j.coph.2013.08.003. Epub 2013 Aug 28.
6
The genetic architecture of methotrexate toxicity is similar in Drosophila melanogaster and humans.甲氨蝶呤毒性的遗传结构在黑腹果蝇和人类中相似。
G3 (Bethesda). 2013 Aug 7;3(8):1301-10. doi: 10.1534/g3.113.006619.
7
Novel oxidatively activated agents modify DNA and are enhanced by ercc1 silencing.新型氧化激活剂可修饰 DNA,并可通过 ercc1 沉默增强。
Chem Res Toxicol. 2012 Nov 19;25(11):2542-52. doi: 10.1021/tx300337j. Epub 2012 Oct 22.
脱氧胞苷激酶基因单核苷酸多态性与 6 种胰腺癌细胞系吉西他滨化疗敏感性的关系。
Chin Med J (Engl). 2011 Feb;124(3):419-22.
4
The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C.延长给药速率吉西他滨的药理学优势仅限于胞苷脱氨酶c.79A>C变异等位基因的患者。
Asia Pac J Clin Oncol. 2011 Mar;7(1):65-74. doi: 10.1111/j.1743-7563.2010.01354.x. Epub 2010 Dec 30.
5
Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours.平衡核苷转运蛋白 1 基因型、胞苷脱氨酶活性和年龄可预测实体瘤患者吉西他滨的血药清除率。
Br J Clin Pharmacol. 2011 Mar;71(3):437-44. doi: 10.1111/j.1365-2125.2010.03838.x.
6
Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome.多药耐药基因多态性与胰腺癌预后的关系。
Cancer. 2011 Feb 15;117(4):744-51. doi: 10.1002/cncr.25510. Epub 2010 Oct 4.
7
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.吉西他滨代谢和转运体基因多态性与局部晚期胰腺癌患者的药物毒性和疗效相关。
Cancer. 2010 Nov 15;116(22):5325-35. doi: 10.1002/cncr.25282.
8
Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms.日本癌症患者中吉西他滨及其代谢物的群体药代动力学:遗传多态性的影响。
Clin Pharmacokinet. 2010 Aug;49(8):549-58. doi: 10.2165/11532970-000000000-00000.
9
Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach.拷贝数变异与胞嘧啶类似物细胞毒性:全基因组关联研究方法。
BMC Genomics. 2010 Jun 4;11:357. doi: 10.1186/1471-2164-11-357.
10
Uncovering the roles of rare variants in common disease through whole-genome sequencing.通过全基因组测序揭示常见疾病中罕见变异的作用。
Nat Rev Genet. 2010 Jun;11(6):415-25. doi: 10.1038/nrg2779.